ArticleClinical proteomics2022

Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues.

Emily R Penick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.